Risks and uncertainties that may cause actual results to differ materially include, among others: gene therapy is still novel with only a few approved treatments so far; AGTC cannot predict when or if it will obtain regulatory approval to commercialize a product candidate or receive reasonable reimbursement; uncertainty inherent in clinical trials and the regulatory review process; risks and uncertainties associated with drug development and commercialization; the direct and indirect impacts of the ongoing COVID-19 pandemic on the Company’s business, results of operations, and financial condition; factors that could cause actual results to differ materially from those described in the forward-looking statements are set forth under the heading "Risk Factors" in the Company’s most recent annual or quarterly report and in other reports AGTC has filed with the SEC.

Disclaimer. © 2020 Market data provided is at least 10-minutes delayed and hosted by

The biotechnology company can be reached via phone at 386-462-2204.Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. BEAT THE MARKET BY 22% PER QUARTER first; 1 of 3663; last × TRADE OUR PREMIUM AND PLATINUM SIGNALS. AGTC Stock Analysis Overview . As of June 30th, there was short interest totaling 2,950,000 shares, an increase of 59.5% from the June 15th total of 1,850,000 shares. Find market predictions, AGTC financials and market news. )+[a-z]{2,63}/i);}, failureMessage: "Value must not contain any URL's"});field11.add(Validate.Presence, {failureMessage:"This field is required"});field11.add(Validate.Length, {tooShortMessage:"Invalid length for field value", tooLongMessage: "Invalid length for field value", minimum: 4, maximum: 4});function handleFormSubmit(ele) { var submitButton = ele.querySelector('input[type=submit]'); var spinner = document.createElement('span'); spinner.setAttribute('class', 'loader'); submitButton.setAttribute('disabled', true); submitButton.style.cursor = 'wait'; submitButton.parentNode.appendChild(spinner); return true; }function resetSubmitButton(e){ var submitButtons = e.target.form.getElementsByClassName('submit-button'); for(var i=0;i

Top institutional investors include Sofinnova Investments Inc. (4.44%), Portolan Capital Management LLC (3.05%), Bank of New York Mellon Corp (0.28%), Russell Investments Group Ltd. (0.24%), Bank of America Corp DE (0.10%) and New York State Common Retirement Fund (0.08%).

FREE DISCOVERY. According to present data Hemp's HEMP shares and potentially its market environment have been in bearish cycle last 12 months (if exists). )+[a-z]{2,})$/i, failureMessage: "A valid email address is required"});var dom2 = document.querySelector('#form1783 #field2');var field2 = new LiveValidation(dom2, {validMessage: "", onlyOnBlur: false, wait: 300});field2.add(Validate.Presence, {failureMessage:"This field is required"});var dom11 = document.querySelector('#form1783 #field11');var field11 = new LiveValidation(dom11, {validMessage: "", onlyOnBlur: false, wait: 300});field11.add(Validate.Custom, {against: function(value) {return !value.match(/(telnet|ftp|https?):\/\/(?:[a-z0-9][a-z0-9-]{0,61}[a-z0-9]\.|[a-z0-9]\.

When autocomplete results are available use up and down arrows to review and enter to select.

Quick Links All rights reserved.

Free predictions up to 10%; Premium and Platinum forecasts; Delayed predictions; Free forever; Forecasts by mail if subscribed; SUBSCRIBE $ 49 /month PREMIUM. Applied Genetic Technologies Corporation has collaboration agreements with Synpromics Limited and University of Florida; Bionic Sight, LLC; and Otonomy, Inc.

The high price target for AGTC is $25.00 and the low price target for AGTC is $7.50.